findmyKOL
Clinical trialNCT00440726CompletedPhase 1/PHASE2Interventional

Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)

SponsorTherapeutic Advances in Childhood Leukemia ConsortiumEnrollment31Acute Lymphoblastic Leukemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Sydney Children'S Hospital

    Randwick, New South Wales, Australia

  • the Children'S Hospital at Westmead

    Westmead, New South Wales, Australia

Brazil
  • Universidade Federale de Sao Paulo/hospital Sao Paulo

    São Paulo, Brazil

Canada
  • Sick Kids

    Toronto, Ontario, Canada

United States
  • City of Hope

    Duarte, California, United States

  • Miller Children'S Hospital

    Long Beach, California, United States

  • Childrens Hospital Los Angeles

    Los Angeles, California, United States

  • Children'S Hospital & Research Center Oakland

    Oakland, California, United States

  • Stanford University Medical Center

    Palo Alto, California, United States

  • Ucsf School of Medicine

    San Francisco, California, United States

  • Children'S National Medical Center

    Washington D.C., District of Columbia, United States

  • University of Miami Cancer Center

    Miami, Florida, United States

  • Children'S Healthcare of Atlanta

    Atlanta, Georgia, United States

  • Ann & Robert H. Lurie Children'S Hospital of Chicago

    Chicago, Illinois, United States

  • Johns Hopkins / Sydney Kimmel Cancer Center

    Baltimore, Maryland, United States

  • Dana Farber Cancer Center

    Boston, Massachusetts, United States

  • C.S. Mott Children'S Hospital

    Ann Arbor, Michigan, United States

  • Childrens Hospital & Clinics of Minnesota

    Minneapolis, Minnesota, United States

  • Children'S Hospital New York-Presbyterian

    New York, New York, United States

  • New York University Medical Center

    New York, New York, United States

  • Levine Children'S Hospital

    Charlotte, North Carolina, United States

  • Nationwide Children'S Hospital

    Columbus, Ohio, United States

  • Primary Children'S Hospital

    Salt Lake City, Utah, United States

  • Seattle Children'S Hospital

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Aug 2006
Primary completion
26 Feb 2011
Completion
26 Feb 2011
Last update posted
19 Feb 2020
Registered enrollment
31
Registry id
NCT00440726

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.